Liou Jesse, Kiliddar Hussein, Iliadis Elias A, Abouzgheib Wissam
Division of Pulmonary Medicine, Cooper University Hospital, Camden, USA.
Division of Cardiology, Cooper University Hospital, Camden, USA.
Cureus. 2025 Jan 18;17(1):e77611. doi: 10.7759/cureus.77611. eCollection 2025 Jan.
Pulmonary infarction is commonly treated with therapy directed at the underlying etiology, a pulmonary embolism. Typically, anti-coagulation and supportive care are all that is needed. Advanced invasive therapy, such as catheter-directed thrombectomy, is a viable option, however, indications for this remain controversial. To our knowledge, we present the first case of a patient diagnosed with intermediate-risk pulmonary embolism, with no right ventricular (RV) dysfunction, that developed progressive pulmonary infarction and hypoxemia, and was successfully treated with aspiration thrombectomy. This highlights the need for consideration and the potential of mechanical thrombectomy, especially as proficiencies and technologies develop.
肺梗死通常采用针对潜在病因(肺栓塞)的治疗方法。一般来说,抗凝治疗和支持性护理就足够了。然而,诸如导管定向血栓切除术等高级侵入性治疗也是一种可行的选择,但其适用指征仍存在争议。据我们所知,我们报告了首例被诊断为中度风险肺栓塞且无右心室功能障碍的患者,该患者出现了进行性肺梗死和低氧血症,并通过抽吸血栓切除术成功治愈。这凸显了考虑机械血栓切除术的必要性及其潜力,尤其是随着技术水平和专业技能的发展。